Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer

Metabolic reprogramming, including the Warburg effect, is a hallmark of cancer. Indeed, the diversity of cancer metabolism leads to cancer heterogeneity, but accurate assessment of metabolic properties in tumors has not yet been undertaken. Here, we performed absolute quantification of the expression levels of 113 proteins related to carbohydrate metabolism and antioxidant pathways, in stage III colorectal cancer surgical specimens from 70 patients. The Warburg effect appeared in absolute protein levels between tumor and normal mucosa specimens demonstrated. Notably, the levels of proteins associated with the tricarboxylic citric acid cycle were remarkably reduced in the malignant tumors which had relapsed after surgery and treatment with 5‐fluorouracil‐based adjuvant therapy. In addition, the efficacy of 5‐fluorouracil also decreased in the cultured cancer cell lines with promotion of the Warburg effect. We further identified nine and eight important proteins, which are closely related to the Warburg effect, for relapse risk and 5‐fluorouracil benefit, respectively, using a biomarker exploration procedure. These results provide us a clue for bridging between metabolic protein expression profiles and benefit from 5‐fluorouracil adjuvant chemotherapy.

[1]  R. Gillies,et al.  Metabolic Profiling of healthy and cancerous tissues in 2D and 3D , 2017, Scientific Reports.

[2]  T. Natsume,et al.  Determination of Rate-Limiting Factor for Formation of Beta-Catenin Destruction Complexes Using Absolute Protein Quantification. , 2017, Journal of proteome research.

[3]  Katsuhisa Horimoto,et al.  A large-scale targeted proteomics assay resource based on an in vitro human proteome , 2016, Nature Methods.

[4]  A. Vazquez,et al.  Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis , 2015, Nature Cell Biology.

[5]  Barbara Mayer,et al.  Impact of the spheroid model complexity on drug response. , 2015, Journal of biotechnology.

[6]  R. Deberardinis,et al.  Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.

[7]  John M. Asara,et al.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function , 2014, Nature.

[8]  B. Kuster,et al.  Mass-spectrometry-based draft of the human proteome , 2014, Nature.

[9]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[10]  Pier Paolo Pandolfi,et al.  Cancer metabolism: fatty acid oxidation in the limelight , 2013, Nature Reviews Cancer.

[11]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[12]  Carolyn Ritterson Lew,et al.  Targeting of Several Glycolytic Enzymes Using RNA Interference Reveals Aldolase Affects Cancer Cell Proliferation through a Non-glycolytic Mechanism , 2012, The Journal of Biological Chemistry.

[13]  M. Sporn,et al.  NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.

[14]  R. Aebersold,et al.  Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.

[15]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[16]  Weidong Zhou,et al.  Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. , 2012, Journal of proteome research.

[17]  H. Lehrach,et al.  Pyruvate Kinase Triggers a Metabolic Feedback Loop that Controls Redox Metabolism in Respiring Cells , 2011, Cell metabolism.

[18]  Arul M Chinnaiyan,et al.  Metabolism unhinged: IDH mutations in cancer , 2011, Nature Medicine.

[19]  S. Yoshida,et al.  Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC) , 2011, Cancer Chemotherapy and Pharmacology.

[20]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[21]  S. Paik,et al.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Devilee,et al.  Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? , 2010, Current opinion in genetics & development.

[23]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[24]  D. Steindler,et al.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. , 2009, Cancer research.

[25]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[26]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[27]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[28]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[29]  G Smith,et al.  The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma , 2005, Gut.

[30]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[31]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[32]  R. Tibshirani,et al.  REJOINDER TO "LEAST ANGLE REGRESSION" BY EFRON ET AL. , 2004, math/0406474.

[33]  D. Madigan,et al.  [Least Angle Regression]: Discussion , 2004 .

[34]  R. Martino,et al.  Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. , 2002, The oncologist.

[35]  J. Macdonald.  Adjuvant therapy for colon cancer , 1997 .

[36]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[37]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[38]  T. Pretlow,et al.  Glucose‐6‐phosphate dehydrogenase: A possible clinical indicator for prostatic carcinoma , 1982, Cancer.

[39]  O. Warburg,et al.  The Metabolism of Carcinoma Cells , 1925 .

[40]  L. V. van't Veer,et al.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[42]  Emmanuel Mitry,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.